Gene · 1075
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rapid sorting and auxiliary evaluation of malignant breast tumors by accurate imaging analysis of metastasis-related biomarker. | Sci Adv | 2025 | 40173246 | PubTator, text mining | PubMed |
Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase-1 inhibitor, in healthy volunteers: An integrated phase 1, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study. | Br J Clin Pharmacol | 2025 | 40170587 | PubTator, text mining | PubMed |
| Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial. | Lancet Respir Med | 2025 | 40154523 | PubTator, text mining | PubMed |
| Construction and Validation of T-cell Exhaustion-related Gene Signature for Predicting Prognosis in Diffuse Large B-cell Lymphoma. | Curr Pharm Biotechnol | 2025 | 40108912 | PubTator, text mining | PubMed |
| Dancing with DPP-1: The Inflammatory Tango of Bronchiectasis. | Am J Respir Crit Care Med | 2025 | 39965048 | PubTator, text mining | PubMed |
| Genetic risk variants implicate impaired maintenance and repair of periodontal tissues as causal for periodontitis-A synthesis of recent findings. | Periodontol 2000 | 2025 | 39953674 | PubTator, text mining | PubMed |
| Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial. | Am J Respir Crit Care Med | 2025 | 39938076 | PubTator, text mining | PubMed |
| Isolation, synthesis and structure-activity relationships of gallotannin derivatives as cathepsin C inhibitor. | Bioorg Med Chem Lett | 2025 | 39933615 | PubTator, text mining | PubMed |
| [Annual review of bronchiectasis 2024]. | Zhonghua Jie He He Hu Xi Za Zhi | 2025 | 39914842 | PubTator, text mining | PubMed |
| Haim-Munk syndrome caused by mutation in the CTSC gene in an Indian consanguineous family. | Indian J Dermatol Venereol Leprol | 2025 | 39912152 | PubTator, text mining | PubMed |
| Dexamethasone mitigates sulfur mustard-induced stem cell deficiency in vivo in rabbit limbal tissue by reducing inflammation and oxidative stress. | Arch Toxicol | 2025 | 39904901 | PubTator, text mining | PubMed |
| Brensocatib in patients with bronchiectasis: subgroup analyses from the WILLOW trial. | ERJ Open Res | 2025 | 39872387 | PubTator, text mining | PubMed |
| Predicting Outcomes in Esophageal Squamous Cell Carcinoma Using scRNA-Seq and Bulk RNA-Seq: A Model Development and Validation Study. | Cancer Med | 2025 | 39840762 | PubTator, text mining | PubMed |
| A comprehensive analysis to reveal the underlying molecular mechanisms of natural killer cell in thyroid carcinoma based on single-cell RNA sequencing data. | Discov Oncol | 2025 | 39808350 | PubTator, text mining | PubMed |
| The di-leucine motif in the host defense peptide LL-37 is essential for initiation of autophagy in human macrophages. | Cell Rep | 2025 | 39708316 | PubTator, text mining | PubMed |
| Design and synthesis of novel cathepsin C inhibitors with anti-inflammatory activity. | RSC Med Chem | 2025 | 39635544 | PubTator, text mining | PubMed |
| Targeting neutrophil serine proteases in bronchiectasis. | Eur Respir J | 2025 | 39467608 | PubTator, text mining | PubMed |
| A randomized phase I study of the safety and pharmacokinetics of BI 1291583 in healthy Japanese male subjects. | Br J Clin Pharmacol | 2025 | 39299301 | PubTator, text mining | PubMed |
| Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study. | Eur Respir J | 2025 | 39255990 | PubTator, text mining | PubMed |
| Papillon-Lefevre syndrome: Case series. | J Oral Maxillofac Pathol | 2024 | 39949702 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1075/papers?page=8